2015 in review: FDA approval of new drugs

Drug Discovery Today

Volumn 21, Issue 7, 2016, Pages 1046-1050

  Kinch, Michael S ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; ORPHAN DRUG;

COMMERCIAL PHENOMENA; DRUG APPROVAL; DRUG INDUSTRY; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; HUMAN; OUTCOME ASSESSMENT; REVIEW; DRUG MANUFACTURE; UNITED STATES;

DRUG APPROVAL; ORPHAN DRUG PRODUCTION; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84964311621     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2016.04.008     Document Type: Short Survey

References (10)

1. M.S. Kinch, and et al. An overview of FDA-approved new molecular entities: 1827-2013 Drug Discov. Today 19 2014 1033 1039
2. M.S. Kinch, and et al. Trends in pharmaceutical targeting of clinical indications: 1930-2013 Drug Discov. Today 19 2014 1682 1685
3. M.S. Kinch 2014 in review: FDA approval of new drugs Drug Discov. Today 2015 10.1016/j.drudis.2015.06.004
4. J.R. Empfield, and M.P. Clark Reducing Drug Attrition 2014 Springer
5. J.L. LaMattina Devalued and Distrusted: Can the Pharmaceutical Industry Restore Its Broken Image 2012 John Wiley & Sons
6. T. Brennan, and W. Shrank New expensive treatments for hepatitis C infection JAMA 312 2014 593 594
7. M. Senior Sovaldi makes blockbuster history, ignites drug pricing unrest Nat. Biotechnol. 32 2014 501 502
8. A. Pollack Drug goes from $13.50 a tablet to $750, overnight New York Times 2015 September 20
9. A. Tefferi, and et al. In support of a patient-driven initiative and petition to lower the high price of cancer drugs Mayo Clinic Proc. 90 2015 996 1000
10. M.S. Kinch The rise (and decline?) of biotechnology Drug Discov. Today 19 2014 1686 1690